Covidien Ltd. (NYSE: COV; BSX: COV) announced today that its Board of Directors has declared a quarterly cash dividend of $0.16 per common share. The dividend is payable on August 11, 2008, to shareholders of record on July 28, 2008.
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry–leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2007 revenue of nearly $9 billion, Covidien has more than 42,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business.
